Vanadium-based nanozyme
1 paper2 findings
- 1 lab in 1 country
- Funders: Basic and Applied Basic Research Foundation of Guangdong Province and 4 more
- Animals1
Outcomes
2Myocardial infarction
downin rats1
1 study
Myocardial infarction
downin rats1
Vanadium-based nanozyme decreases myocardial infarction in rats.
“local injection of MXene-TA into the infarcted myocardium reprogrammed metabolism, activated NAD+-dependent pathways, attenuated oxidative damage in cardiomyocytes, decreased infarct area, and enhanced myocardial function”
Animalsin a rat MI modelheart
Research (Washington, D.C.)28 Oct 2025
Cellular senescence
downin mice1
1 study
Cellular senescence
downin mice1
Vanadium-based nanozyme decreases cellular senescence in mice.
“In aged (24-month-old) mice, systemic MXene-TA administration restored NAD+/NADH homeostasis and reduced senescence markers (p16, p21, γH2AX, and SASP) in the heart, liver, and spleen”
AnimalsMXene-TA
Research (Washington, D.C.)28 Oct 2025